Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 91,623,594
- Share change
- -521,758
- Total reported value
- $10,912,571,096
- Put/Call ratio
- 87%
- Price per share
- $119.10
- Number of holders
- 285
- Value change
- -$75,880,031
- Number of buys
- 153
- Number of sells
- 113
Report period
Q1 2018
Institutions
285
Top holders
10
ALNY full security history
Newer quarter: Q2 2018
Previous quarter: Q4 2017
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
14,875,621
|
$1,889,948,000 | — | 31 Dec 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
9.2%
|
12,233,241
|
$1,554,233,000 | — | 31 Dec 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.9%
|
9,182,530
|
$1,166,640,000 | — | 31 Dec 2017 | |
| DODGE & COX |
13F
|
Company |
6.2%
|
8,231,595
|
$1,045,824,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
7,263,914
|
$922,880,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
7,115,063
|
$903,969,000 | — | 31 Dec 2017 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2.7%
|
3,611,014
|
$458,779,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
2,002,389
|
$254,402,000 | — | 31 Dec 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1%
|
1,394,213
|
$177,134,762 | — | 31 Dec 2017 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
1%
|
1,338,300
|
$170,031,000 | — | 31 Dec 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1%
|
1,330,802
|
$169,079,000 | — | 31 Dec 2017 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.91%
|
1,217,367
|
$154,666,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.89%
|
1,187,544
|
$150,877,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.88%
|
1,168,770
|
$148,492,000 | — | 31 Dec 2017 | |
| BB BIOTECH AG |
13F
|
Company |
0.79%
|
1,051,338
|
$133,572,000 | — | 31 Dec 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.71%
|
941,600
|
$119,630,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
747,646
|
$94,929,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0.56%
|
742,261
|
$94,304,000 | — | 31 Dec 2017 | |
| 12 West Capital Management LP |
13F
|
Company |
0.53%
|
700,000
|
$88,935,000 | — | 31 Dec 2017 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.47%
|
629,080
|
$79,924,000 | — | 31 Dec 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.43%
|
571,398
|
$72,596,000 | — | 31 Dec 2017 | |
| Polar Capital LLP |
13F
|
Company |
0.39%
|
516,232
|
$65,587,000 | — | 31 Dec 2017 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
500,219
|
$63,553,000 | — | 31 Dec 2017 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.37%
|
493,619
|
$62,714,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
474,609
|
$60,299,000 | — | 31 Dec 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.34%
|
450,000
|
$57,173,000 | — | 31 Dec 2017 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.34%
|
449,655
|
$57,129,000 | — | 31 Dec 2017 | |
| Slate Path Capital LP |
13F
|
Company |
0.34%
|
447,000
|
$56,791,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
395,267
|
$50,219,000 | — | 31 Dec 2017 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.27%
|
358,774
|
$45,582,000 | — | 31 Dec 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.27%
|
353,474
|
$44,909,000 | — | 31 Dec 2017 | |
| Swiss National Bank |
13F
|
Company |
0.25%
|
326,500
|
$41,482,000 | — | 31 Dec 2017 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.23%
|
309,039
|
$39,263,000 | — | 31 Dec 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
302,376
|
$38,417,000 | — | 31 Dec 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.22%
|
290,000
|
$36,845,000 | — | 31 Dec 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
272,720
|
$34,649,000 | — | 31 Dec 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
262,416
|
$33,340,000 | — | 31 Dec 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.19%
|
256,802
|
$32,627,000 | — | 31 Dec 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.19%
|
255,316
|
$32,438,000 | — | 31 Dec 2017 | |
| ROCKEFELLER FINANCIAL SERVICES INC |
13F
|
Company |
0.19%
|
246,931
|
$31,373,000 | — | 31 Dec 2017 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.18%
|
239,816
|
$30,469,000 | — | 31 Dec 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.17%
|
225,834
|
$28,692,000 | — | 31 Dec 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.16%
|
217,081
|
$27,580,000 | — | 31 Dec 2017 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.16%
|
211,455
|
$26,865,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
211,117
|
$26,819,000 | — | 31 Dec 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.15%
|
200,000
|
$25,410,000 | — | 31 Dec 2017 | |
| Casdin Capital, LLC |
13F
|
Company |
0.15%
|
200,000
|
$25,410,000 | — | 31 Dec 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.15%
|
196,038
|
$24,907,000 | — | 31 Dec 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
173,757
|
$22,081,000 | — | 31 Dec 2017 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.12%
|
158,946
|
$20,194,000 | — | 31 Dec 2017 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q1 2018
As of 31 Mar 2018,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
285 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,623,594 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., DODGE & COX, BAILLIE GIFFORD & CO, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, and PERCEPTIVE ADVISORS LLC.
This page lists
285
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
275
Q1 2018 holders
285
Holder diff
10
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.